NIH-funded research R21 grant

Investigating how reactive astrocytes affect synapses in Alzheimer's disease

Official title: Reactive Astrogliosis and the Tripartite Synapse in Alzheimer's Disease

Funded at Massachusetts General Hospital · NIH-11052689 · Data updated 2026-11-12

This study is looking at how certain brain cells, called reactive astrocytes, affect the health of connections between brain cells in people with Alzheimer's disease, to help find new ways to protect memory and thinking skills.

More s Disease research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2026
Funding year2025
Award (this year)$452,550
NIH project number1R21AG087072-01A1
Project IDNIH-11052689 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those exhibiting early signs of cognitive decline.

Less likely to help

Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.

What this research studies

This research focuses on understanding the role of reactive astrocytes in Alzheimer's disease, particularly how they influence synaptic health. The study examines the balance between harmful and protective effects of these cells in the context of amyloid-beta and tau protein toxicity. By analyzing the upregulation of a specific protein called GFAP in reactive astrocytes, the research aims to clarify their contribution to synaptic loss and cognitive decline in Alzheimer's patients. This could lead to new insights into potential therapeutic targets for improving synaptic function.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preserving cognitive function in Alzheimer's disease patients.

How similar studies have gone: Previous research has shown promising results in understanding the role of astrocytes in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Serrano-Pozo, Alberto — Massachusetts General Hospital
  • Study coordinator: Serrano-Pozo, Alberto

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.